Evidence map›Paper›PMID 42158770›Full record

ArticleCureus2026

The Use of Amantadine in a Nontraumatic Disorder of Consciousness: A Case Report.

Mary Hanna, Joe Chen, Diana Salama

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mary HannaFamily Medicine, Loma Linda University Medical Center, Loma Linda, USA.
Joe ChenFamily Medicine, Loma Linda University Medical Center, Loma Linda, USA.
Diana SalamaFamily Medicine, Loma Linda University Medical Center, Loma Linda, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disorders of consciousness (DoC) are among the most challenging conditions encountered in clinical practice, often complicating both diagnosis and management. Although amantadine has demonstrated benefit in facilitating recovery in patients with traumatic brain injury (TBI)-related DoC, its impact on nontraumatic causes has not been well established. We describe the case of an elderly patient with persistent encephalopathy following an ischemic stroke who experienced marked neurological improvement shortly after initiation of amantadine therapy. This case highlights the potential role of amantadine as a therapeutic option in non-TBI-related disorders of consciousness.

Indexed as

amantadinebrain trauma injurydisorders of consciousnessstimulantsstroke

Identifiers

PMID42158770
PMCPMC13180999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.